Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker.


Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
2022
Historique:
received: 05 10 2021
accepted: 07 02 2022
entrez: 18 2 2022
pubmed: 19 2 2022
medline: 19 2 2022
Statut: epublish

Résumé

Barrett's esophagus (BE) is a precursor of the esophageal adenocarcinoma (EAC). BE- development and its progression to cancer is associated with gastroesophageal reflux disease. However, there is currently no molecular risk prediction model that accurately identifies patients at high risk for EAC. Here, we investigated the impact of shortened telomeres in a mouse model for Barrett esophagus (L2-IL1B). The L2-IL1B mouse model is characterized by IL-1β-mediated inflammation, which leads to a Barrett-like metaplasia in the transition zone between the squamous forestomach and glandular cardia/stomach. Telomere shortening was achieved by mTERC knockout. In the second generation (G2) of mTERC knockout L2-IL1B.mTERC

Identifiants

pubmed: 35178191
doi: 10.18632/oncotarget.28198
pii: 28198
pmc: PMC8842791
doi:

Substances chimiques

Biomarkers 0
IL1B protein, human 0
Interleukin-1beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

347-359

Informations de copyright

Copyright: © 2022 Sahm et al.

Déclaration de conflit d'intérêts

CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.

Références

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1451-7
pubmed: 16896031
Cancer Res. 2004 Oct 15;64(20):7629-33
pubmed: 15492292
Cell Cycle. 2012 Dec 1;11(23):4328-38
pubmed: 23095673
Am J Pathol. 2002 Apr;160(4):1259-68
pubmed: 11943711
Ann Oncol. 2012 Dec;23(12):3155-3162
pubmed: 22847812
Nat Commun. 2014 Oct 29;5:5224
pubmed: 25351503
Gastroenterology. 2019 Aug;157(2):492-506.e2
pubmed: 30998992
Mod Pathol. 2006 Jun;19(6):772-9
pubmed: 16557277
Nature. 2003 Nov 13;426(6963):194-8
pubmed: 14608368
Neoplasia. 2004 Jan-Feb;6(1):85-92
pubmed: 15068673
Cancer Res. 2006 May 1;66(9):4766-73
pubmed: 16651430
Mol Cell. 2004 May 21;14(4):501-13
pubmed: 15149599
Curr Biol. 2003 Sep 2;13(17):1549-56
pubmed: 12956959
Oncogene. 2009 Dec 3;28(48):4225-36
pubmed: 19734944
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Discov. 2013 Oct;3(10):1130-41
pubmed: 23779129
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
Nat Genet. 2009 Oct;41(10):1138-43
pubmed: 19718028
Gastrointest Endosc Clin N Am. 2003 Apr;13(2):369-97
pubmed: 12916666
Lung Cancer. 2015 Jun;88(3):297-303
pubmed: 25840848
Cancer Cell. 2012 Jan 17;21(1):36-51
pubmed: 22264787
Carcinogenesis. 2012 Jan;33(1):113-8
pubmed: 22072619
Science. 1995 Sep 1;269(5228):1267-70
pubmed: 7544492
J Clin Invest. 2012 Jun;122(6):2283-8
pubmed: 22622037
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Am J Gastroenterol. 2001 Oct;96(10):2839-48
pubmed: 11693316
Nature. 1991 Apr 18;350(6319):569-73
pubmed: 1708110
Gastroenterology. 2018 Jan;154(2):406-420
pubmed: 29037468
Cancer Prev Res (Phila). 2017 Jan;10(1):55-66
pubmed: 27807078
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell. 1999 May 14;97(4):515-25
pubmed: 10338215
Cell. 1999 May 14;97(4):527-38
pubmed: 10338216
Cell. 1997 Oct 3;91(1):25-34
pubmed: 9335332
Int J Cancer. 2016 May 15;138(10):2322-33
pubmed: 26455580
Virchows Arch. 2018 Jan;472(1):43-54
pubmed: 29500519
Nat Genet. 2000 Sep;26(1):114-7
pubmed: 10973262
Int J Biochem Cell Biol. 2005 May;37(5):977-90
pubmed: 15743672
Cell Mol Life Sci. 2004 Mar;61(6):641-56
pubmed: 15052408
Lancet. 2009 Mar 7;373(9666):850-61
pubmed: 19269522
Cancer Res. 2003 Aug 15;63(16):5021-7
pubmed: 12941829
Cell. 1999 Mar 5;96(5):701-12
pubmed: 10089885
Cell Stem Cell. 2015 Jun 4;16(6):601-12
pubmed: 26046760
Cytometry A. 2004 Apr;58(2):120-31
pubmed: 15057965
Gastroenterology. 2020 Aug;159(2):575-590
pubmed: 32325086
Philos Trans R Soc Lond B Biol Sci. 1998 Jun 29;353(1370):915-23
pubmed: 9684289
PLoS One. 2017 Mar 31;12(3):e0174833
pubmed: 28362812
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3931-6
pubmed: 17360455
Gastroenterology. 2010 Mar;138(3):854-69
pubmed: 20080098
Cancer Res. 2001 Nov 15;61(22):8284-9
pubmed: 11719461
Carcinogenesis. 2021 Apr 17;42(3):405-413
pubmed: 33068426
Stem Cells Int. 2016;2016:3710836
pubmed: 26697073
Nat Genet. 2001 Jun;28(2):155-9
pubmed: 11381263

Auteurs

Vincenz Sahm (V)

II Medizinische Klinik, Technische Universität München, Munich, Germany.

Carlo Maurer (C)

II Medizinische Klinik, Technische Universität München, Munich, Germany.

Theresa Baumeister (T)

II Medizinische Klinik, Technische Universität München, Munich, Germany.
Klinik für Innere Medizin II, Universitätsklinikum Freiburg, Freiburg, Germany.

Akanksha Anand (A)

II Medizinische Klinik, Technische Universität München, Munich, Germany.

Julia Strangmann (J)

II Medizinische Klinik, Technische Universität München, Munich, Germany.
Klinik für Innere Medizin II, Universitätsklinikum Freiburg, Freiburg, Germany.

Roland M Schmid (RM)

II Medizinische Klinik, Technische Universität München, Munich, Germany.

Timothy C Wang (TC)

Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Michael Quante (M)

II Medizinische Klinik, Technische Universität München, Munich, Germany.
Klinik für Innere Medizin II, Universitätsklinikum Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH